Cordis, a worldwide leader in the development and manufacturing of interventional cardiovascular and endovascular technology, strongly supports the decision made by the Centers for Medicare & Medicaid Services (CMS) to expand coverage of carotid artery stenting (CAS) cms.gov. This expansion in coverage will allow patients that suffer from carotid artery disease expanded access to minimally invasive endovascular carotid therapy. ...
Sensor can potentially provide an easy, low-cost alternative to expensive footwear modifications...
This initiative will promote intellectual property and public health: Dr Jitendra Singh ...
UL Solutions helps Michigan's growing medical device industry enhance products' safety, security, usability and interoperability with new testing services in Rochester Hills....
Novel platform for structural heart interventions now in human use, with ability to improve patient recovery and reduce anesthesia and hospital stays...
Brainomix Awarded Innovate UK Grant to Collaborate with Swiss-based Nanoflex Robotics...
Neoss Group, a leading innovator in dental implant solutions, is proud to announce that it has received EU Medical Device Regulation (MDR) certification by its Notified Body, the BSI Group, the Netherlands B.V. for its implants and abutments. ...
Rhaeos, Inc, a clinical stage medical device technology company, is pleased to announce that it has been awarded a $1.5 million grant (Federal Award # 1UG3NS130338) from the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) through its Blueprint MedTech program. This grant will further the development of its FDA breakthrough designated medical technology designed to transform the management of hydrocephalus, a neurological condition affecting ove...
New roles and additional footprint expansion to support global growth...
To identify patients with the MSI biomarker who may be eligible for potential treatment with Jemperli ...
